[New antiamebic drugs: bismuth glycolylarsanilate and fumagillin].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001152:Arsenicals / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D003510:Cyclohexanes; D004404:Dysentery, Amebic / Q000628:therapy*; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes
D000900:Anti-Bacterial Agents; D001152:Arsenicals; D003510:Cyclohexanes; D005231:Fatty Acids, Unsaturated; D012717:Sesquiterpenes; C026211:fumagillin; D001729:Bismuth
AMEBIASIS, INTESTINAL/therapy; ANTIBIOTICS/therapeutic use; BISMUTH-ARSENIC COMPOUNDS/therapeutic use
Nuevos medicamentos antiamebianos: glicolilarsanilato de bismuto y fumagilin.